Second Sight Medical Products Inc (NASDAQ: EYES) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating.
Last second sight medical products, inc earnings: 8/6 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations: investors.secondsight.com/investor-relations
| Impact snapshot | Event time: | EYES | ||||
|---|---|---|---|---|---|---|
|
Last Price
|
Price Change
|
Price Change %
|
Volume Shares
|
Max Up
|
Max Down
|
Volume Ratio
%
|
Performance comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last price | ||
| VWAP | ||
|
High:
|
Max up |
High:
|
|
Low:
|
Max down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event Day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance Since Event
Time and Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
SIGN UP TODAY
Opt-in for
EYES alerts
EYES alerts
from News Quantified
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
EYES alerts
High impacting Second Sight Medical Products, Inc news events
Weekly update
A roundup of the hottest topics
EYES
News
- Second Sight Medical Products Inc (NASDAQ: EYES) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $1.00 price target on the stock.MarketBeat
- Second Sight Medical Products, Inc. (EYES) CEO Will McGuire on Q2 2019 Results - Earnings Call Transcript [Seeking Alpha]Seeking Alpha
- Second Sight Reports Second Quarter 2019 Financial ResultsBusiness Wire
- Second Sight to Discuss Second Quarter 2019 Financial Results on August 6, 2019 Conference CallBusiness Wire
- Researchers Present Latest Positive Results of Second Sight’s Orion Visual Cortical Prosthesis Feasibility StudyBusiness Wire
- More
EYES
SEC Filings
- 8/20/19 - Form 4
- 8/6/19 - Form 10-Q
- 8/6/19 - Form 8-K
- EYES's page on the SEC website
- More